Navigation Links
YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain

MISSISSAUGA, ON, May 02, 2007 /PRNewswire-FirstCall/ - YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced top-line results from its randomized, placebo-controlled Phase IIb trial of AeroLEF(TM) in opioid naive patients with post-operative pain following orthopedic surgery. AeroLEF(TM) met the primary endpoint of the study, showing a statistically significant difference in SPRID4 from placebo (p=0.0194).

AeroLEF(TM) is a unique, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain. Unlike fixed dose approaches to opioid delivery, where a significant titration period is often required to determine the suitable dose for the patient, AeroLEF(TM) is being developed as a non-invasive patient self-titrated delivery system designed to enable patients to identify and select a personalized dose for each pain episode, achieving both rapid onset and extended duration of analgesia.

The trial evaluated the SPRID4 for AeroLEF(TM) compared with placebo for the treatment of the first pain episode. SPRID4 is a summary of the combined changes in pain relief and in pain intensity that patients report over the first 4 hours following initiation of dosing. The trial also examined a number of secondary endpoints including various measurements of pain relief, pain intensity, as well as onset and duration of analgesia, that are commonly used as indicators of efficacy for acute pain products. Various safety measurements were also examined.

"These results continue to demonstrate the unique potential for AeroLEF(TM) to be further developed into a valuable product for pain management across a broad range of indications, which could include post-operative pain, medical emergency pain and breakthrough pain," said David All
'"/>




Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
(Date:11/9/2009)... , INDIANAPOLIS, Nov. 9 AMD L...laser expert, Dr. James Jesse, has accepted the po...Jesse will be responsible for overseeing research ... lasers, standards and compliance for continuing e...eer reviews and trade publications, and lecturing ...
(Date:11/9/2009)... , LAKE MARY, Fla., Nov. 9 Ac... provider of outsourced implantable medical device...announced today that it is relocating its corporat...rompted by the firm,s continued rapid growth, incl...ary office space that will open in January 2010 an...
(Date:11/9/2009)... , ANN ARBOR, Mich., Nov. 9 ...e of Clinical Xpert(TM) CareFocus, a leading clini...o identify at-risk patients in real-time and respo...uce total cost of treatment. ,, This upgrade is...ditional cost. ,, CareFocus 2.0 contains seve...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Global warming increasing the dispersal of flora in Northern forests 8800 1Global warming increasing the dispersal of flora in Northern forests 8800 2Cinergy Health Expands Staff in Face of Dramatic Growth 48618 1Cinergy Health Expands Staff in Face of Dramatic Growth 48618 2Dr Philip A DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees 48614 1Dr Philip A DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees 48614 2
(Date:11/9/2009)...s available in French . , , Montreal, Novemb...le and female. In human bodies trillions of cells ...ich they are composed. Yet these don,t come in tw...ters. Because these complex cell networks are the ...g searched for ways to splice cell clusters down t...
(Date:11/9/2009)... Nov. 9, 2009 The first human embryonic stem cell...as been shown to restore limb function in rats wit...expand the clinical trial to include people with c...ug Administration gave Geron Corp. of Menlo Park, ... in individuals with thoracic spinal cord injuries...
(Date:11/9/2009)...long-term risks, but not all agree , , M...with a saline solution might have soothing short-t...prone to infections in the long run by stripping y...hing the nose, we are removing the bad mucus but, ... that contains the antimicrobial agents as well," ...
(Date:11/9/2009)... Partnership to Combine Self-service Kiosk... Denver, CO (PRWEB) Novemb...rp) and AHA endorsed Vecna Technologies announced ...ntrol when interacting with providers by understan.... FHSCorp’s HFMA peer reviewed product, Cle...
(Date:11/9/2009)..., Nov. 9 In the wake of...g a call to action to all mental health profession... ,, Give an Hour(TM) is a national nonprofit or...tal health services to active duty service members..., and veterans of Iraq and Afghanistan who have se...
Breaking Medicine News(10 mins):Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2Health News:Sinus Rinses May Do More Harm Than Good 2Health News:Sinus Rinses May Do More Harm Than Good 3Health News:FHS Corp. Announces Partnership with Vecna Technologies 2Health News:Give an Hour(TM) Partners with American Red Cross and Calls All Mental Health Professionals in Texas to Volunteer Their Services 2
...experts of Johns Hopkins joined the aid efforts by...ed after the Hurricane Katrina. // The devastating...ippi on August 29, took more than 1,200 lives. Eve...n DNA analysis of human remains after the terroris...
...pkins researchers have induced mutations in mice t...g basic motor skills. // The study mainly aims at ...cific steps they take to control a neuron's abilit...K1 protein and AMPA receptors interact with specif...
...ers from Canada and India have reported in the onl...has seen a significant decline by almost one-third...es is attributed to the increased use of protectio...Southern and Northern part of India. The basis of ...
...t clinical trial of gene therapy is underway for m...he clinical trial for Duchenne muscular dystrophy ...apy that was developed over two decades by scienti...at Columbus Children's Hospital in Ohio, an affili...
... investigators at the cancer treatment center in H...coming a safe and reliable source of detecting bre...ng of the Anderson, of the centre said that they a...and so they should not wait to seek medical attent...
... in Sydney has shown that children who grow up wit...hose who live in a cat free house. // The studies ... cats as pets, found that if they acquired a cat i...he research said that said while children who had ...
Other Medicine News:Health News:Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims 2Health News:Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims 3Health News:Understanding Basic Motor Skills 2Health News:Rates of HIV infection shows a sharp decline in south India 2Health News:First Gene Therapy Human Trial For Muscular Dystrophy In Progress 2Health News:First Gene Therapy Human Trial For Muscular Dystrophy In Progress 3Health News:Strengthen Your Childs Immunity Give Him A Cat 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: